Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial

BACKGROUND: Patient-reported outcomes are integral in benefit–risk assessments of new treatment regimens. The PALOMA-2 study provides the largest body of evidence for patient-reported health-related quality of life (QOL) for patients with metastatic breast cancer (MBC) receiving first-line endocrine...

Descripción completa

Detalles Bibliográficos
Autores principales: Rugo, H S, Diéras, V, Gelmon, K A, Finn, R S, Slamon, D J, Martin, M, Neven, P, Shparyk, Y, Mori, A, Lu, D R, Bhattacharyya, H, Bartlett, C Huang, Iyer, S, Johnston, S, Ettl, J, Harbeck, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913649/
https://www.ncbi.nlm.nih.gov/pubmed/29360932
http://dx.doi.org/10.1093/annonc/mdy012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913649/
https://www.ncbi.nlm.nih.gov/pubmed/29360932
http://dx.doi.org/10.1093/annonc/mdy012

Ejemplares similares